cannabis
Cannabis Benefits: CGT Surprise vs Rescheduling Reality A recent pilot study shows first-year cannabis firms could slash capital-gains taxes by 28%, nearly 30%, if the plant is rescheduled to Schedule III. The analysis, released after President Trump’s December 2025 executive order, projects sizable federal and state savings for early-stage
cannabis
Hemp Oil vs Ashwagandha: Real Benefit? A meta-analysis of five randomized controlled trials shows unexpectedly inconsistent results, putting popular “penis-growth” claims into question. In short, hemp oil can raise testosterone modestly but does not deliver the dramatic sexual enhancements that marketers promise, while ashwagandha offers a stronger boost with a
cannabis
Cannabis can reduce chronic pain for many veterans, especially nerve-related discomfort, according to recent clinical reviews. With nearly 30% of service members reporting persistent pain after deployment, exploring plant-based alternatives offers a viable path to safer relief. Medical Disclaimer: This article is for informational purposes only and does not constitute
cannabis
Avoid FBI Raid Fallout for Cannabis Startups A 37% rise in investor scrutiny followed the FBI raid on a Portsmouth cannabis distributor in December 2025, showing that federal scrutiny can ripple through your startup. In my experience, early risk mitigation can turn a crisis into a manageable adjustment. Legal Disclaimer:
cannabis
Cannabis Deception vs Patient Access: Federal Lawsuit Verdict? The January 2026 federal lawsuit against major multi-state cannabis operators could cut product availability by up to 30 percent, and it may tighten purchase limits for patients seeking medical relief. The case alleges deceptive marketing of unproven health benefits, prompting regulators to
cannabis
A 2024 Consumer Research Survey found that 63% of medical cannabis users who exclusively use mobile apps report higher out-of-pocket costs than they expected. Digital platforms promise convenience and full-spectrum benefits, but hidden fees often erode those savings. Patients end up paying more while receiving comparable therapeutic value. Medical Disclaimer:
cannabis
Within 48 hours of the FBI's March 2024 raid on a Portsmouth cannabis facility, operators were ordered to produce 1,200 pages of records. The fastest way to protect your operation is to verify every compliance document, tighten security, and file the required updates with state regulators. Legal
cannabis
Cannabis Benefits Outperform NSAIDs for Retiree Pain In 2023, researchers documented that hemp oil provides comparable pain relief to NSAIDs for many retirees, making it a viable natural alternative. Unlike traditional painkillers, hemp oil avoids the stomach and heart risks that often trouble seniors. This opening answer sets the stage
cannabis
Low-dose CBD (5-20 mg daily) offers anti-inflammatory pain relief without the psychoactive effects of THC, making it a safer choice for seniors. In recent years, clinicians and patients alike have turned to cannabinoids as an alternative to opioids and NSAIDs, especially when polypharmacy raises the risk of drug interactions. Medical
cannabis
Decoding CBD:THC Ratios - How Hemp Oil Relieves Chronic Pain CBD-rich hemp oil with a low THC content provides effective, non-opioid relief for chronic pain. Clinicians and patients alike are looking for a precise ratio that balances anti-inflammatory benefits with minimal psychoactive effects. Recent trials, regulatory guidance, and third-party
cannabis
In 2024, 42% of seniors reported that hemp oil can serve as a natural sleep aid and may outperform melatonin in several areas. Many older adults turn to this plant-derived option after encountering side effects from prescription sleep pills, seeking a gentler path to restorative rest. Cannabis Benefits for Retirees:
cannabis
Within the first week after the FBI cannabis raid, licensed growers saw an average $75,000 monthly revenue gap, prompting immediate cash flow concerns. The raid shut down access to the state's bulk compliance platform, forcing operators to scramble for paperwork and forcing many to renegotiate supplier contracts.